Optimizing Polyethylene Glycol Coating for Stealth Nanodiamonds
ACS Applied Materials & Interfaces · 02.04.2025 · 17 (13) · 19304-19316
DOI: 10.1021/acsami.4c21303 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 24.03.2025. Verfasst von Edoardo Donadoni und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Materials Science, University of Milano-Bicocca, Via R. Cozzi 55, Milano 20125, Italy. Hauptthemen laut MEDLINE: Polyethylene Glycols, Nanodiamonds. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell?Istruzione, dell?Universit? e della Ricerca.
Abstract (Originalsprache)
Nanodiamonds (NDs) have emerged as potential candidates for versatile platforms in nanomedicine, offering unique properties that enhance their utility in drug delivery, imaging, and therapeutic applications. To improve their biocompatibility and nanomedical applicability, NDs are coated with organic polymer chains, such as poly(ethylene glycol) (PEG), which are well known to prolong their blood-circulating lifetime by reducing the surface adsorption of serum proteins. Theoretical simulations are useful tools to define, at the atomic level, the optimal parameters that guide the presentation of the coating chains in the biological environment and the interaction of coated NDs with proteins. In this work, we perform atomistic molecular dynamics (MD) simulations of several PEGylated spherical ND models immersed in a realistic physiological medium. In particular, we evaluate the effect of the polymer chain's terminal group, length, grafting density, and the ND core dimension on both the structural properties of the PEG coating and the interaction of the nanoconjugates with the aqueous phase. Moreover, we investigate the role played by the chemical nature of the core material through a comparative analysis with a PEGylated spherical titanium dioxide (TiO2) nanoparticle (NP). Among all the parameters evaluated, we find that the PEG grafting density, the PEG chain length, and the NP core material are key factors in determining the dynamic behavior of PEGylated nanosystems in solution, whereas the PEG terminal group and the ND dimension only play a marginal role. These factors can be strategically adjusted to identify the optimal conditions for enhanced clinical performance. Finally, we prove that the PEG coating prevents the aggregation of two ND particles. We believe that this computational study will provide valuable insights to the experimental community, supporting the rational design of polymer-coated inorganic NPs for more efficient nanomedical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Materials Science, University of Milano-Bicocca, Via R. Cozzi 55, Milano 20125, Italy.
- BioNanoMedicine Center NANOMIB, University of Milano-Bicocca, Milano 20125, Italy.
ORCID-Profile: Edoardo Donadoni, Paulo Siani, Davide Campi, Giulia Frigerio, Cristiana Di Valentin
Förderung
- Ministero dell?Istruzione, dell?Universit? e della Ricerca
Zitieren
APA
Donadoni, E., Siani, P., Gambari, S., Campi, D., Frigerio, G., & Di Valentin, C. (2025). Optimizing Polyethylene Glycol Coating for Stealth Nanodiamonds. ACS Applied Materials & Interfaces, 17(13), 19304-19316. https://doi.org/10.1021/acsami.4c21303
Vancouver
Donadoni E, Siani P, Gambari S, Campi D, Frigerio G, Di Valentin C. Optimizing Polyethylene Glycol Coating for Stealth Nanodiamonds. ACS Applied Materials & Interfaces. 2025;17(13):19304-19316. doi:10.1021/acsami.4c21303
BibTeX
@article{Donadoni2025,
author = {Donadoni, Edoardo and Siani, Paulo and Gambari, Simone and Campi, Davide and Frigerio, Giulia and Di Valentin, Cristiana},
title = {Optimizing Polyethylene Glycol Coating for Stealth Nanodiamonds},
journal = {ACS Applied Materials & Interfaces},
year = {2025},
volume = {17},
number = {13},
pages = {19304--19316},
doi = {10.1021/acsami.4c21303}
}
EUVIMED